Search Results

There are 5918 results for: content related to: Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B

  1. Differences in nephrotoxicity risk and renal effects among anti-viral therapies against hepatitis B

    Alimentary Pharmacology & Therapeutics

    Volume 41, Issue 3, February 2015, Pages: 310–319, S. Koklu, M. T. Gulsen, Y. Tuna, H. Koklu, O. Yuksel, M. Demir, R. Guner, Z. Dogan, M. Kucukazman, O. K. Poyrazoglu, M. Biyik, N. A. Ozturk, T. Aydogan, S. Coban, O. Kocaman, F. Sapmaz, S. H. Gokturk, C. Karaca, A. Demirezer, A. Tanoglu, B. Yildirim, A. Altinbas, B. M. Atak, A. M. Cosar, E. Alkan and Other collaborators

    Article first published online : 4 DEC 2014, DOI: 10.1111/apt.13036

  2. You have free access to this content
    Review article: nucleos(t)ide analogues in patients with chronic hepatitis B virus infection and chronic kidney disease

    Alimentary Pharmacology & Therapeutics

    Volume 39, Issue 1, January 2014, Pages: 35–46, C. Pipili, E. Cholongitas and G. Papatheodoridis

    Article first published online : 29 OCT 2013, DOI: 10.1111/apt.12538

  3. You have free access to this content
    Resolution of adefovir-related nephrotoxicity by adefovir dose-reduction in patients with chronic hepatitis B

    Alimentary Pharmacology & Therapeutics

    Volume 37, Issue 7, April 2013, Pages: 710–719, J. L. Hartono, M. O. Aung, Y. Y. Dan, M. Gowans, K. Lim, Y. M. Lee, G. H. Lee, H. C. Low, P. S. Tan, M. A. Thwin, C. Soon, L.-L. Chiu, M. J. Khoo, E. Koay and S. G. Lim

    Article first published online : 21 FEB 2013, DOI: 10.1111/apt.12251

  4. You have free access to this content
    Randomised clinical trial: the benefit of combination therapy with adefovir and lamivudine for chronic hepatitis B

    Alimentary Pharmacology & Therapeutics

    Volume 35, Issue 9, May 2012, Pages: 1027–1035, M. G. Ghany, J. J. Feld, X. Zhao, T. Heller, E. Doo, Y. Rotman, P. Nagabhyru, C. Koh, D. E. Kleiner, E. C. Wright, T. J. Liang and J. H. Hoofnagle

    Article first published online : 26 MAR 2012, DOI: 10.1111/j.1365-2036.2012.05059.x

  5. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Article first published online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  6. Efficacy of tenofovir switch therapy for nucleos(t)ide-experienced patients with chronic hepatitis B

    Alimentary Pharmacology & Therapeutics

    Volume 41, Issue 11, June 2015, Pages: 1190–1199, A. O.-S. Lo, V. W.-S. Wong, G. L.-H. Wong, Y.-K. Tse, H.-Y. Chan and H. L.-Y. Chan

    Article first published online : 31 MAR 2015, DOI: 10.1111/apt.13185

  7. You have free access to this content
    Management options for lamivudine-resistant chronic hepatitis B patients with suboptimal virological suppression by adefovir

    Alimentary Pharmacology & Therapeutics

    Volume 34, Issue 8, October 2011, Pages: 972–981, A. Ong, V. W.-S. Wong, G. L.-H. Wong, H.-Y. Chan, C.-H. Tse and H. L.-Y. Chan

    Article first published online : 24 AUG 2011, DOI: 10.1111/j.1365-2036.2011.04833.x

  8. You have free access to this content
    Meta-analysis: oral anti-viral agents in adults with decompensated hepatitis B virus cirrhosis

    Alimentary Pharmacology & Therapeutics

    Volume 35, Issue 6, March 2012, Pages: 674–689, A. K. Singal and R. J. Fontana

    Article first published online : 19 JAN 2012, DOI: 10.1111/j.1365-2036.2011.04990.x

  9. The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis B on long-term nucleos(t)ide analogue therapy

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 11-12, December 2014, Pages: 1262–1269, C. S. Coffin, M. Rezaeeaval, J. X. Pang, L. Alcantara, P. Klein, K. W. Burak and R. P. Myers

    Article first published online : 13 OCT 2014, DOI: 10.1111/apt.12990

  10. You have free access to this content
    Letter: renal tubular dysfunction during nucleotide analogue therapy in chronic hepatitis B – author's reply

    Alimentary Pharmacology & Therapeutics

    Volume 36, Issue 10, November 2012, Page: 993, J. H. Hoofnagle

    Article first published online : 16 OCT 2012, DOI: 10.1111/apt.12074

  11. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Article first published online : 1 OCT 2012, DOI: 10.1002/hep.26040

  12. In vitro, ex vivo, and in situ intestinal absorption characteristics of the antiviral ester prodrug adefovir dipivoxil

    Journal of Pharmaceutical Sciences

    Volume 89, Issue 8, August 2000, Pages: 1054–1062, Pieter Annaert, Josef J. Tukker, Jan van Gelder, Lieve Naesens, Erik de Clercq, Guy van den Mooter, Renaat Kinget and Patrick Augustijns

    Article first published online : 18 JUL 2000, DOI: 10.1002/1520-6017(200008)89:8<1054::AID-JPS10>3.0.CO;2-5

  13. You have free access to this content
    Undetectable HBV DNA at month 12 of entecavir treatment predicts maintained viral suppression and HBeAg-seroconversion in chronic hepatitis B patients at 3 years

    Alimentary Pharmacology & Therapeutics

    Volume 35, Issue 11, June 2012, Pages: 1326–1335, G. L.-H. Wong, V. W.-S. Wong, H.-Y. Chan, P. C.-H. Tse, J. Wong, A. M.-L. Chim, K. K.-L. Yiu, S. H.-T. Chu and H. L.-Y. Chan

    Article first published online : 16 APR 2012, DOI: 10.1111/j.1365-2036.2012.05098.x

  14. You have free access to this content
    Chronic hepatitis B

    Hepatology

    Volume 45, Issue 2, February 2007, Pages: 507–539, Anna S. F. Lok and Brian J. McMahon

    Article first published online : 26 JAN 2007, DOI: 10.1002/hep.21513

  15. Absence of a Pharmacokinetic Interaction Between Entecavir and Adefovir

    The Journal of Clinical Pharmacology

    Volume 47, Issue 10, October 2007, Pages: 1327–1334, Mr Marc Bifano, Dr Jing-He Yan, Dr Robert A. Smith, Dr Duxi Zhang, Dr Dennis M. Grasela and Dr Frank LaCreta

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270007304780

  16. You have free access to this content
    Letter: renal effects of tenofovir in adefovir dipivoxil-experienced HBV patients

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 3, August 2014, Page: 324, A. Marengo, M. Marietti, M. Rizzetto and A. Marzano

    Article first published online : 9 JUL 2014, DOI: 10.1111/apt.12839

  17. Do different lamivudine-resistant hepatitis B genotypes carry the same risk of entecavir resistance?

    Journal of Medical Virology

    Volume 85, Issue 1, January 2013, Pages: 26–33, Guan Huei Lee, Myat Oo Aung, Yock Young Dan, Yin Mei Lee, Belinda Mak, How Cheng Low, Kieron Lim, Maung Aye Thwin, Poh Seng Tan and Seng Gee Lim

    Article first published online : 28 SEP 2012, DOI: 10.1002/jmv.23392

  18. Entecavir plus adefovir versus adefovir plus lamivudine in hepatitis B virus e antigen-positive, lamivudine-resistant chronic hepatitis B

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 7, July 2014, Pages: 1485–1493, Jeong Heo, Sang Hoon Ahn, Young-Oh Kweon, Byung-Ho Kim, Henry L Y Chan, Andrzej Horban, Suchat Wongcharatrawee, Cyril Llamoso and Kwan Sik Lee

    Article first published online : 15 JUL 2014, DOI: 10.1111/jgh.12567

  19. You have free access to this content
    Abstracts 890 to 1096

    Hepatology

    Volume 46, Issue S1, October 2007, Pages: 632A–724A,

    Article first published online : 19 SEP 2007, DOI: 10.1002/hep.22020

  20. You have free access to this content
    Meta-analysis: antiviral treatment for hepatitis D

    Alimentary Pharmacology & Therapeutics

    Volume 35, Issue 6, March 2012, Pages: 663–673, C. Triantos, M. Kalafateli, V. Nikolopoulou and A. Burroughs

    Article first published online : 24 JAN 2012, DOI: 10.1111/j.1365-2036.2012.04993.x